When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Osher Günsberg chats about how his relationship with his wife and family inspired him to defeat chronic back pain.

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

( MENAFN - GlobeNewsWire - Nasdaq) Stem Cell Therapy market Size Was Valued at USD 12.05 Billion in 2023, and is Projected to Reach USD 31.33 Billion by 2032, Growing at a CAGR of 11.20% From ...

The Company is currently developing SPC-15 as an intranasal treatment for PTSD SARASOTA, FL, Nov. 18, 2024 (GLOBE NEWSWIRE) - ...

Experts are calling for extra funding to speed up treatment for the more than three quarters of a million women currently on ...

Both studies were presented at the American College of Rheumatology (ACR) annual meeting.

Experts are calling for extra funding to speed up treatment for the more than three quarters of a million women currently on ...

CHEST infections are not out of the norm for this time of year – but sometimes the symptoms could be a sign of something more ...

Tharimmune, Inc. ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of ...

There, she acquired a rare set of equine surgery skills while developing an interest in regenerative medicine, the promising ...